We report the outcome of a high-throughput small-molecule screen to identify novel, nontoxic, inhibitors of Trypansoma cruzi, as potential starting points for therapeutics to treat for both the acute and chronic stages of Chagas disease. Two compounds were identified that displayed nanomolar inhibition of T. cruzi and an absence of activity against host cells at the highest tested dose. These compounds have been registered with NIH Molecular Libraries Program (probes ML157 and ML158).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2011.09.057 | DOI Listing |
Publication Analysis
Top Keywords
inhibitors trypansoma
8
trypansoma cruzi
8
identification small-molecule
4
small-molecule inhibitors
4
cruzi replication
4
replication report
4
report outcome
4
outcome high-throughput
4
high-throughput small-molecule
4
small-molecule screen
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!